# Population PK Analysis Plan for Pembrolizumab Phase 1 Dose-Escalation Oncology Study

## 1. Study Context
- **Indication:** Oncology
- **Compound:** Pembrolizumab
- **Trial Phase:** Phase 1 Dose-Escalation
- **Primary Analysis Objective:** Characterize population pharmacokinetics and identify key sources of variability

## 2. Data Sources
- Comprehensive collection of PK samples from dose-escalation cohorts
- Intensive sampling in early cohorts
- Sparse sampling in later expansion cohorts
- Collection of comprehensive demographic and clinical covariate data

## 3. Modeling Approach
### 3.1 Exploratory Data Analysis
- Descriptive statistics of PK concentrations
- Visualization of concentration-time profiles
- Preliminary covariate trend identification
- Outlier detection and data cleaning

### 3.2 Structural PK Model
- Initial 2-compartment model with linear elimination
- Test absorption models (first-order, with potential lag time)
- Evaluate linear vs. nonlinear clearance mechanisms

### 3.3 Variability Modeling
- Inter-individual variability on clearance and volume parameters
- Evaluation of exponential random effects model
- Assessment of parameter shrinkage

### 3.4 Covariate Analysis
Potential covariates to investigate:
- Demographics: Age, weight, sex
- Disease characteristics: Tumor type, stage
- Organ function: Renal function, hepatic function
- Concomitant medications

Covariate selection strategy:
- Stepwise forward addition/backward elimination
- Significance threshold: p < 0.01
- Clinically relevant change: >20% in key PK parameter

## 4. Model Evaluation
- Goodness-of-fit plots
- Visual Predictive Checks (VPC)
- Bootstrap uncertainty quantification
- Normalized Prediction Distribution Errors (NPDE)

## 5. Simulation Plan
- Exposure predictions across dose levels
- Subgroup exposure estimations
- Potential dose adjustment scenarios

## 6. Software and Computing
- **Modeling:** NONMEM (version 7.4)
- **Visualization:** R (tidyverse, ggplot2)
- **Version Control:** Git repository

## 7. Reporting
- Comprehensive PopPK report
- Model code and datasets
- Presentation materials for stakeholders